Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06702891

Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is an observational study with a case control design. This study included patients with gastric cancer confirmed by pathological diagnosis of gastric tissue, and matched the control population according to age, gender, etc. In this study, researchers collected clinical information and multiple biological samples such as serum and tissue tissue from the study subjects. The researchers combined exosome sequencing, proteomics and single-cell RNA sequencing to explore the heterogeneity of cardia cancer, identify specific biomarkers and potential therapeutic targets for cardia cancer, and provide a basis for the development of new diagnostic tools and therapeutic strategies.

Conditions

Interventions

TypeNameDescription
OTHERDetection of biological samples based on exosome sequencing, proteomics and single-cell RNA sequencingThe researchers combined exosome sequencing, proteomics and single-cell RNA sequencing to explore the heterogeneity of cardia cancer, identify specific biomarkers and potential therapeutic targets for cardia cancer.

Timeline

Start date
2024-12-17
Primary completion
2025-10-01
Completion
2027-10-01
First posted
2024-11-25
Last updated
2025-02-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06702891. Inclusion in this directory is not an endorsement.